Please provide your email address to receive an email when new articles are posted on . Platysma prominence treatment with 26 to 36 units of onabotulinumtoxinA was well-tolerated and had a favorable ...
In both phase 3 trials, onabotulinumtoxinA significantly improved platysma band severity at maximum contraction compared with placebo. The Food and Drug Administration (FDA) has approved Botox ® ...
(RTTNews) - Allergan Aesthetics, an AbbVie company (ABBV), announced that FDA approves BOTOX® Cosmetic for temporary improvement in the appearance of moderate to severe vertical bands connecting the ...
IRVINE, Calif., Oct. 18, 2024 /PRNewswire/ -- Today, Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced the U.S. FDA approval of BOTOX® Cosmetic for temporary improvement in the appearance ...
The FDA warning letters mostly went to cosmetic websites. In each case, the FDA said the companies were offering unofficial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results